In this video, Eleonora Teplinsky, MD, discusses results of the HER2CLIMB-05 study, showing that adding tucatinib to first-line maintenance therapy improved patient outcomes in HER2-positive ...
Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback